Recombinant Human LMTK3 Protein，His & SUMO

LMTK3 (Lipid-Protein Kinase 3) is a member of the serine/threonine kinase family, which has garnered significant interest in recent years due to its potential roles in various biological processes and diseases, particularly in cancer and neurological disorders. This protein is implicated in the regulation of several key cellular functions, including cell signaling, proliferation, differentiation, and apoptosis. Research has shown that LMTK3 may influence the progression of cancer by modulating pathways associated with tumor growth and metastasis, making it a promising target for therapeutic interventions. Additionally, studies have indicated that LMTK3 may play a role in the maintenance of neuronal health, suggesting its involvement in neurodegenerative diseases. Given its multifaceted functions, there is an increasing demand to produce recombinant LMTK3 for detailed biochemical and structural studies. The recombination process facilitates the production of large quantities of the protein, enabling researchers to investigate its enzymatic activity, binding interactions, and structural characteristics, which are crucial for understanding its biological roles and developing inhibitors or activators. As such, the generation of recombinant LMTK3 not only contributes to basic scientific knowledge but also holds potential for translational applications in drug discovery and development, especially in targeting therapeutic strategies for cancer and neurodegenerative diseases.